跳至主要内容
临床试验/NCT06771375
NCT06771375尚未招募不适用

Eye Movement Desensitization and Reprocessing (EMDR) to Treat Chronic Pruritus in a Multidisciplinary Tertiary Care Setting- a Feasibility Study

University Hospital, Basel, Switzerland2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
2
主要终点
Adherence (%)

研究概览

简要总结

Pruritus is a common symptom of numerous dermatological and non-dermatological conditions. Current treatments for chronic pruritus (CP) are often not fully effective and may have burdensome side effects. Recently, the trauma exposure technique Eye Movement Desensitization and Reprocessing (EMDR) that is recommended as first line treatment for posttraumatic stress disorder has been reported to be also effective in the treatment of CP in anecdotal clinical case observations. However, to the best of the investigator's knowledge, the efficacy of EMDR in CP has not yet been systematically explored. This study aims at addressing this unmet need in a prospective pilot study comparing EMDR versus treatment as usual (TAU).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Provided written informed consent
  • Age 18 to 75 years
  • Skindex-29 (questionnaire) symptoms subscale ≥42
  • Confirmed diagnosis CP
  • Itch intensity of min. ≥ 4 on the 0-10 numerical rating scale within the last 7 days
  • Stable course of treatment in the two weeks prior to the study

排除标准

  • Inability to follow the procedures of the study, e.g. due to language problems, severe psychiatric disorders such as delusional disorder, suicidality or dementia.
  • Patients on phototherapy
  • Acute attacks of an autoimmune disease such as Crohn's disease
  • Serious cardiac disease

结局指标

主要结局

Adherence (%)

时间窗: up to 8 month

Adherence/ receipt of intervention and retention will be assessed by tracking % of sessions completed, number of dropouts and number of patients completing final assessment.

次要结局

未报告次要终点

研究者

发起方
University Hospital, Basel, Switzerland
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验